These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16766774)

  • 1. Effect of a nutritional supplementation on bone health in Chilean elderly subjects with femoral osteoporosis.
    Bunout D; Barrera G; Leiva L; Gattas V; de la Maza MP; Haschke F; Steenhout P; Klassen P; Hager C; Offord E; Hirsch S
    J Am Coll Nutr; 2006 Jun; 25(3):170-7. PubMed ID: 16766774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial.
    Meier C; Woitge HW; Witte K; Lemmer B; Seibel MJ
    J Bone Miner Res; 2004 Aug; 19(8):1221-30. PubMed ID: 15231008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone favorably affects bone turnover and bone mineral density in patients with short bowel syndrome undergoing intestinal rehabilitation.
    Tangpricha V; Luo M; Fernández-Estívariz C; Gu LH; Bazargan N; Klapproth JM; Sitaraman SV; Galloway JR; Leader LM; Ziegler TR
    JPEN J Parenter Enteral Nutr; 2006; 30(6):480-6. PubMed ID: 17047171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW; de Nijs RN; Lems WF; Geusens PP; Laan RF; Huisman AM; Algra A; Buskens E; Hofbauer LC; Oostveen AC; Bruyn GA; Dijkmans BA; Bijlsma JW
    J Rheumatol; 2007 May; 34(5):1051-7. PubMed ID: 17407214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃.
    Rossini M; Gatti D; Viapiana O; Fracassi E; Idolazzi L; Zanoni S; Adami S
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E622-6. PubMed ID: 22298802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in blood and urinary cadmium levels and bone mineral density according to osteoporosis medication in individuals with an increased cadmium body burden.
    Eom SY; Yim DH; Hong SM; Kim YD; Kim H; Choi BS; Park JD; Park CH; Kim GB; Yu SD
    Hum Exp Toxicol; 2018 Apr; 37(4):350-357. PubMed ID: 28441892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a Multispecies Probiotic Supplement on Bone Health in Osteopenic Postmenopausal Women: A Randomized, Double-blind, Controlled Trial.
    Jafarnejad S; Djafarian K; Fazeli MR; Yekaninejad MS; Rostamian A; Keshavarz SA
    J Am Coll Nutr; 2017; 36(7):497-506. PubMed ID: 28628374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized placebo-controlled trial.
    Storm D; Eslin R; Porter ES; Musgrave K; Vereault D; Patton C; Kessenich C; Mohan S; Chen T; Holick MF; Rosen CJ
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3817-25. PubMed ID: 9814452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone health in long-term gastric cancer survivors: A prospective study of high-dose vitamin D supplementation using an easy administration scheme.
    Climent M; Pera M; Aymar I; Ramón JM; Grande L; Nogués X
    J Bone Miner Metab; 2018 Jul; 36(4):462-469. PubMed ID: 28766134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early changes in biochemical markers of bone turnover predict bone mineral density response to antiresorptive therapy in Korean postmenopausal women with osteoporosis.
    Kim SW; Park DJ; Park KS; Kim SY; Cho BY; Lee HK; Shin CS
    Endocr J; 2005 Dec; 52(6):667-74. PubMed ID: 16410657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial.
    Hampson G; Martin FC; Moffat K; Vaja S; Sankaralingam S; Cheung J; Blake GM; Fogelman I
    Osteoporos Int; 2003 Sep; 14(9):750-6. PubMed ID: 12904840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis.
    Deane A; Constancio L; Fogelman I; Hampson G
    BMC Musculoskelet Disord; 2007 Jan; 8():3. PubMed ID: 17214897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
    Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
    J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Vitamin D, Calcium and Leucine-Enriched Whey Protein Nutritional Supplement Improves Measures of Bone Health in Sarcopenic Non-Malnourished Older Adults: The PROVIDE Study.
    Hill TR; Verlaan S; Biesheuvel E; Eastell R; Bauer JM; Bautmans I; Brandt K; Donini LM; Maggio M; Mets T; Seal CJ; Wijers SL; Sieber C; Cederholm T; Aspray TJ;
    Calcif Tissue Int; 2019 Oct; 105(4):383-391. PubMed ID: 31338563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
    Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers.
    Kurland ES; Cosman F; McMahon DJ; Rosen CJ; Lindsay R; Bilezikian JP
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3069-76. PubMed ID: 10999788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a mixture of calcium, vitamin D, inulin and soy isoflavones on bone metabolism in post-menopausal women: a retrospective analysis.
    Bevilacqua M; Righini V; Certan D; Gandolini G; Alemanni M
    Aging Clin Exp Res; 2013 Dec; 25(6):611-7. PubMed ID: 23907774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of vitamin D and calcium supplementation on bone turnover in institutionalized adults with Down's Syndrome.
    Zubillaga P; Garrido A; Mugica I; Ansa J; Zabalza R; Emparanza JI
    Eur J Clin Nutr; 2006 May; 60(5):605-9. PubMed ID: 16391575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.